These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4186456)
41. Management of the nephrotic syndrome in children. McDonald R S Afr Med J; 1970 Nov; 44(46):1315-7. PubMed ID: 5485560 [No Abstract] [Full Text] [Related]
43. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis. Sheth KJ; Liu CC; Good TA Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366 [No Abstract] [Full Text] [Related]
44. Fatal measles pneumonia in a child with chickenpox pneumonia. Lobes LA; Cherry JD JAMA; 1973 Mar; 223(10):1143-4. PubMed ID: 4739372 [No Abstract] [Full Text] [Related]
47. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children]. Podracká L; Böör A; Sasinka M Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041 [TBL] [Abstract][Full Text] [Related]
48. Cyclophosphamide in the treatment of adult nephrotic syndrome. Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697 [No Abstract] [Full Text] [Related]
49. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents. Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990 [TBL] [Abstract][Full Text] [Related]
50. Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts. Strong JS; Bartholomew BA; Smyth CJ Ann Rheum Dis; 1973 May; 32(3):233-7. PubMed ID: 4715541 [No Abstract] [Full Text] [Related]
52. Value and toxicity of therapy for idiopathic nephrotic syndrome in the child. Murphy AV Nephron; 1973; 11(2):163-73. PubMed ID: 4748984 [No Abstract] [Full Text] [Related]
53. [The physico-chemical nature of anti-measles antibodies in children who have had typical measles]. Tikhonova NT; Khrometskaia TM; Kholchev NV; Strel'tsova MP; Nesterova TP Vopr Virusol; 1973; 18(1):27-32. PubMed ID: 4791702 [No Abstract] [Full Text] [Related]
54. [Immunoelectrophoretic studies of blood serum of children with measles]. Pawlicka-Domańska Z; Sliwińska-Przyjemska H Przegl Epidemiol; 1972; 26(2):173-8. PubMed ID: 5070974 [No Abstract] [Full Text] [Related]
55. [Treating juvenile nephrotic syndrome with levamisol: regarding a marketing suspension]. Manrique-Rodríguez S; Martínez-Fernández-Llamazares C; Sanjurjo-Sáez M Farm Hosp; 2010; 34(3):148-9. PubMed ID: 20471571 [No Abstract] [Full Text] [Related]
56. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children]. Starkiewiczowa J; Fydryk J; Lupa B Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844 [No Abstract] [Full Text] [Related]
57. [Childhood nephrotic syndrome with minimun glomerular lesions (clinical development and therapeutic response in 40 cases)]. Ruilope LM; Casado S; López de Novales E; Barat A; Alvarez J; Hernando L Rev Clin Esp; 1973 Nov; 131(4):313-8. PubMed ID: 4772782 [No Abstract] [Full Text] [Related]
58. Cyclophosphamide and the prepubertal testis. Arneil GC Lancet; 1972 Dec; 2(7789):1259-60. PubMed ID: 4117757 [No Abstract] [Full Text] [Related]
59. Cyclophosphamide therapy in the management of nephrotic syndrome. Srivastava RN; Mayekar G; Anand R; Choudhry VP; Ghai OP Indian Pediatr; 1974 Dec; 11(12):767-74. PubMed ID: 4448539 [No Abstract] [Full Text] [Related]
60. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine]. Smorodinova IP; Shikina ES Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]